Your health matters, and so do your rights, let us help you make them heard
Chen S, Li L, Ding W, Zhu Y, Zhou N
Current evidence does not support routine clinical use of GLP-1 medications specifically for alcohol cravings, and patients with alcohol use disorder should be referred to evidence-based treatments including behavioral interventions, mutual support groups, and FDA-approved pharmacotherapies such as naltrexone, acamprosate, and disulfiram
Safety and Best Practices: Prioritise patient safety with comprehensive training on injection site selection, sterile technique, and adverse event management
These medications impact part of the reward center of your brain in a way that reduces the gratification you typically get from drinking alcohol